The real-world safety of atezolizumab as second-line or later treatment in Japanese patients with non-small-cell lung cancer: a post-marketing surveillance study

BACKGROUND: We conducted a post-marketing surveillance study to evaluate the clinical tolerability and safety of atezolizumab in Japanese patients with non-small-cell lung cancer (NSCLC). METHODS: This prospective, observational post-marketing cohort study was conducted in NSCLC patients who receive...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohe, Yuichiro, Yamazaki, Naoya, Yamamoto, Nobuyuki, Murakami, Haruyasu, Yoh, Kiyotaka, Kitano, Shigehisa, Hashimoto, Hideyuki, Murayama, Ayako, Nakane, Sayuri, Gemma, Akihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9157296/
https://www.ncbi.nlm.nih.gov/pubmed/35325169
http://dx.doi.org/10.1093/jjco/hyac024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9157296/
https://www.ncbi.nlm.nih.gov/pubmed/35325169
http://dx.doi.org/10.1093/jjco/hyac024

Ejemplares similares